Skip to content

A prospective randomized controlled trial by LDRf type and conventional type (Japanese taxonomy) for the oesophagus new blood vessel reformulation process clinic observation

A prospective randomized controlled trial by LDRf type and conventional type (Japanese taxonomy) for the oesophagus new blood vessel reformulation process clinic observation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001240
Enrollment
Unknown
Registered
2011-03-24
Start date
2011-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oesophagus new blood vessell reformulation process

Interventions

Trial group:Give the patients endoscopy APC therapy decided by LDRf type for oesophagus regeneration new blood vessel
Control group:Clinically observe the oesophagus regeneration new blood vessel reformulation process

Sponsors

Department of Gastroenterology of the General Hospital of Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: after esophagus variceal eradication therapy

Exclusion criteria

Exclusion criteria: Severity hepatic dysfunction; Serious liver and kidney syndrome

Design outcomes

Primary

MeasureTime frame
variceal vein reformulation process after oesophagus regeneration new blood vessel;

Secondary

MeasureTime frame
the rate of complication;

Countries

China

Contacts

Public ContactEn-qiang LINGHU
linghuenqiang@vip.sina.com+86 13501233558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026